It was reported by Cinader, Dubiski and Wardlaw (1964) that A-strain mice, including in particular mice of the substrain A/HeJ which we have used extensively, lack a component of the complement system which has been subsequently identified by Nilsson and Miiller-Eberhard (1967) as C'5. This is consistent with our own previously unreported finding that, despite precautions to avoid inactivation, including collection over ice (Borsos and Cooper, 1961) , A/HeJ serum (unlike that of CBA and C57BI mice) is completely ineffective when used as a substitute for guinea pig C' in titrating haemolytic and cytotoxic antibody, whereas it is effective in opsonisation tests. Such inhibition of tumour growth as occurs in consequence of treatment of either the tumour cells preceding inoculation or the recipient with ATG, therefore, cannot be attributed to C'-dependent lysis, and the most likely explanation of the observations cited would seem to be that ATG
As already reported (Woodruff and Smith, 1970) , the growth of isogeneic mammary carcinoma transplants in A-strain mice may be inhibited by treating the recipient with heterospecific antitumour globulin (ATG), but the degree of inhibition is variable and never very marked. It was anticipated that preincubation of tumour cells with ATG in the absence of complement (C') before inoculation would have a more decisive effect. As reported below, however, we have found that, while tumour growth may be inhibited to a modest extent following this procedure, it may, on the other hand, be unaffected or even facilitated.
It was reported by Cinader, Dubiski and Wardlaw (1964) that A-strain mice, including in particular mice of the substrain A/HeJ which we have used extensively, lack a component of the complement system which has been subsequently identified by Nilsson and Miiller-Eberhard (1967) as C'5. This is consistent with our own previously unreported finding that, despite precautions to avoid inactivation, including collection over ice (Borsos and Cooper, 1961) Pre-incubation of tumour cells.-2-107cells were incubated in 2-6 ml. Dulbecco's solution containing 6-5 mg. ATG at 37' C. in a water bath. As a rule no C' was included, but as an additional control in the third experiment one group of mice (group 7) were given cells which had been pre-incubated as described above except that 0-65 ml. undiluted guinea pig serum had been added as a source of C'.
RESULTS
The results are summarised in the tables and figures. As reported previously (Woodruff and Boak, 1966) 12, 11, 11, 11, 9, 12, 11 11.0 0-2 ml. s.e. on Day -2 3 C. parvum (W2) 9, 6, 13, 8, 9, 12, 10 9-6 0-2 ml. i.p. on Day -2 4 C. parvum (W2) 9, 10, 8, 7, 11, 9, 10 9.0 0-2 ml. i.v. on Day -2 Statistical comparison of group means by modified t-test (Bailey, 1959) Groups I and 2 : d = 3-37 f = 8 P = 0-01 4 and 2 : d = 3-24 f = 10 P = <0-01
In the second experiment primary transplants to the foot grew more slowly than those to the flank even though the original cell dose was ten times as great (Table II Groups 1, 6 ), but when the foot bearing a primary transplant was amputated and 105 viable cells were re-inoculated to the flank the secondary transplants grew even more rapidly than primary flank transplants (Table II Groups 1, 6; Fig. 2) . Injection of C. parvum 2 days prior to the re-inoculation significantly inhibited the growth of the secondary transplant (Table 11 Groups 6 . 7; Fig. 2) .
In this experiment incubation of tumour cells with ATG before transplantation did not inhibit, indeed if anything it appeared to facilitate, subsequent tumour growth in untreated mice, but it did markedly potentiate the effect of treating the host with C. parvum. This is not apparent 40 days after transplantation but after 56 days the synergistic effect of combining the two procedures is strikingly demonstrated (Table II Groups 1 , 2, 4, 5; Fig. 3 ).
In the third experiment pre-incubation of the cells with ATG without C', though it did not kill the cells, significantly inhibited subsequent tumour growth, and was in effect roughly equivalent to reducing the dose of untreated viable cells by a factor of 10 (Table III Groups 1, 2, 6; Fig. 4, 5) . Pre-incubation with ATG plus C' (Ta'ble III Group 7), which resulted in virtually 100 per cent cell death as judged by a dye exclusion test, was followed by growth of a tumour in only one mouse in the group. In the others small nodules appeared but by Day +58 were still only just palpable (about 1-2 mm. diameter).
The inhibitory effect of C. parvum alone was confirmed (Table III Groups 4, 5; Fig. 5, 6 ). The effect of treating the cells with ATG and the host with C. parvum (Table III Groups 8, 9; Fig. 5, 6 ) was even more dramatic than in the previous experiment and was roughly equivalent to reducing the dose of viable cells in control animals Table III Group 3; Fig. 4) by a factor of 100. Once again W2 was the more effective of the two preparations of C. parvum which were tested (Table III Groups 4, 5, 8, 9; Fig. 5, 6 ). (1) i.p. injection of the host with C. parvum (P2) and (2) pre-incubation of tumour cells with ATG (Batch EM).
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